The definition of Market Access is the process to ensure that the right patients who would benefit from a medication, get rapid and maintained access to the medication, at the right time. These days, both clinical effectiveness and ‘value for money’ are essential and pharma companies must navigate an increasingly complex re-imbursement landscape to make sure the product reaches the patients for whom it is intended.

This course is especially useful to those who want to know what Market Access really is!

Member companies of the Swiss Biotech Association will benefit from a 15 % discount on the registration fee.

  • May 18, 2021 @ 9:00 am

  • May 19, 2021

  • Virtual Classroom - remotely via digital platform

Event starts in
  • 00

  • 00

  • 00


Virtual Classroom - remotely via digital platform

Contact Form